BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:OnKure Therapeutics\, Inc. (OKUR) investor events
X-WR-CALNAME:OnKure Therapeutics\, Inc. (OKUR) investor events
DESCRIPTION:Earnings calls and investor events for OnKure Therapeutics\, In
 c. (OKUR)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for OnKure Therapeutics\, I
 nc. (OKUR)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:eea0d7cb-2bb9-4d78-824f-a915992ee900@equibles.com
DTSTAMP:20260704T035829Z
DTSTART;VALUE=DATE:20251106
DTEND;VALUE=DATE:20251107
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Earnings Call\, FY2025 Q3
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:6569d56f-59f1-426a-b9e7-f9d7a257ebdc@equibles.com
DTSTAMP:20260624T233140Z
DTSTART;VALUE=DATE:20251110
DTEND;VALUE=DATE:20251111
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Conference: Guggenheim Healthcare
  Innovation Conference
DESCRIPTION:Guggenheim Healthcare Innovation Conference\nThe start time has
  not been announced.\nWebcast: https://event.summitcast.com/view/6h3HS7z68
 WnTQE5PS7Vq8J/guest_book?session_id=m688zYJGJsxnHnPsBgWQB7
END:VEVENT
BEGIN:VEVENT
UID:4216cce4-a7e9-4ea7-b7be-1fa35bd31fb1@equibles.com
DTSTAMP:20260624T233140Z
DTSTART;VALUE=DATE:20251112
DTEND;VALUE=DATE:20251113
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Conference: Stifel Healthcare Con
 ference
DESCRIPTION:Stifel Healthcare Conference\nThe start time has not been annou
 nced.\nWebcast: https://event.summitcast.com/view/cwkmPXkC4dosg6MoG95rxb/g
 uest_book?session_id=REMG9bhzx4qEVyqqLypTNi
END:VEVENT
BEGIN:VEVENT
UID:29bbbe8c-24cc-4062-98f3-742e2584f6c4@equibles.com
DTSTAMP:20260624T233140Z
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251204
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Conference: Evercore Healthcare C
 onference
DESCRIPTION:Evercore Healthcare Conference\nThe start time has not been ann
 ounced.\nWebcast: https://wsw.com/webcast/evercore52/register.aspx?conf=ev
 ercore52&page=okur&url=https://wsw.com/webcast/evercore52/okur/2397538
END:VEVENT
BEGIN:VEVENT
UID:38283765-ff4a-4c55-83ac-8ee2d8d0a8ed@equibles.com
DTSTAMP:20260624T233140Z
DTSTART;VALUE=DATE:20260225
DTEND;VALUE=DATE:20260226
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Conference: Oppenheimer 36th Annu
 al Healthcare Life Sciences Conference
DESCRIPTION:Oppenheimer 36th Annual Healthcare Life Sciences Conference\nTh
 e start time has not been announced.\nWebcast: https://event.summitcast.co
 m/view/CTtthLh2Bi2D9aYoKpvtEv/guest_book?session_id=KyGoBGqh7qf75fcHFYGnsQ
END:VEVENT
BEGIN:VEVENT
UID:1a7561b7-b312-4b0f-bbdf-e260afb5b2b8@equibles.com
DTSTAMP:20260624T233140Z
DTSTART;VALUE=DATE:20260310
DTEND;VALUE=DATE:20260311
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Conference: Leerink Global Health
 care Conference
DESCRIPTION:Leerink Global Healthcare Conference\nThe start time has not be
 en announced.\nWebcast: https://event.summitcast.com/view/mT9poctHDNthc6b8
 9WqVjf/guest_book?session_id=o43kRRLfyoBkBDQhgzWDdn
END:VEVENT
BEGIN:VEVENT
UID:58cb8833-1f0a-492d-9c23-6bf2d4e3ccac@equibles.com
DTSTAMP:20260617T191054Z
DTSTART;VALUE=DATE:20260312
DTEND;VALUE=DATE:20260313
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Earnings Call\, FY2025 Q4
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:ecec784e-a7c7-462f-8fad-8aef13bda031@equibles.com
DTSTAMP:20260617T191049Z
DTSTART;VALUE=DATE:20260505
DTEND;VALUE=DATE:20260506
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Earnings Call\, FY2026 Q1
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:0554ca7c-672f-4b33-9393-8632c8591253@equibles.com
DTSTAMP:20261002T212528Z
DTSTART;VALUE=DATE:20260702
DTEND;VALUE=DATE:20260703
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Investor Update: OnKure Therapeut
 ics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selec
 tivity Matters & Pan-Mutant Allosteric Inhibition Delivers\, on July 15\, 
 2026
DESCRIPTION:OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα
  Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibiti
 on Delivers\, on July 15\, 2026\nThe start time has not been announced.\nW
 ebcast: https://onkuretherapeutics.gcs-web.com/node/8896
END:VEVENT
BEGIN:VEVENT
UID:28ec8f81-5ae1-4fdd-968b-873751fb853a@equibles.com
DTSTAMP:20261009T224408Z
DTSTART;VALUE=DATE:20260715
DTEND;VALUE=DATE:20260716
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Investor Update: Virtual KOL Even
 t to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant 
 Allosteric Inhibition Presentation
DESCRIPTION:Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Select
 ivity Matters & Pan-Mutant Allosteric Inhibition Presentation\nThe start t
 ime has not been announced.\nWebcast: https://investors.onkuretherapeutics
 .com/static-files/6158f6b4-402f-445c-870f-f531dde31f51
END:VEVENT
BEGIN:VEVENT
UID:8c79df35-f522-4e0f-9263-4b4cf5cd5455@equibles.com
DTSTAMP:20261002T212528Z
DTSTART:20260715T150000Z
DTEND:20260715T160000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Investor Update: Virtual KOL Even
 t to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant 
 Allosteric Inhibition
DESCRIPTION:Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Select
 ivity Matters & Pan-Mutant Allosteric Inhibition\nWebcast: https://investo
 rs.onkuretherapeutics.com/events/event-details/virtual-kol-event-discuss-p
 i3ka-inhibitor-medicines-selectivity-matters-pan
END:VEVENT
BEGIN:VEVENT
UID:09d344c1-9be7-459e-ae25-a226545f87c5@equibles.com
DTSTAMP:20260915T001258Z
DTSTART;VALUE=DATE:20260804
DTEND;VALUE=DATE:20260805
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Earnings Call\, FY2026 Q2
DESCRIPTION:The start time has not been announced.\nWebcast: https://onkure
 therapeutics.gcs-web.com/node/8921
URL:https://equibles.com/stocks/okur/calls/2026-q2
END:VEVENT
BEGIN:VEVENT
UID:0164275f-361b-46c5-b8f5-fe3fa4ec4b2b@equibles.com
DTSTAMP:20260914T235020Z
DTSTART;VALUE=DATE:20260831
DTEND;VALUE=DATE:20260901
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:OnKure Therapeutics\, Inc. (OKUR) Conference: OnKure Therapeutics t
 o Participate in the Morgan Stanley Global Healthcare Conference
DESCRIPTION:OnKure Therapeutics to Participate in the Morgan Stanley Global
  Healthcare Conference\nThe start time has not been announced.\nWebcast: h
 ttps://onkuretherapeutics.gcs-web.com/node/9036
END:VEVENT
END:VCALENDAR
